SynthesisDigestive diseases and sciences2021

Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials.

Vineet S Rolston et al.PubMed ↗Publisher ↗

No numbers read from the abstract.